Although several disease-causing genes have been identified in OI patients, 85% to 90% of clinical cases were found to be associated with pathogenic variants in COL1A1 or COL1A2 (Claeys et al., 2021), which encode procollagen peptides α1 or α2 of type I collagen. Here, COL1A2 is linked to osteogenesis imperfecta.